These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35289003)

  • 21. DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.
    Ding B; Zhang W; Wu X; Wang J; Xie C; Huang X; Zhan S; Zheng Y; Huang Y; Xu N; Ding X; Gao S
    Oncotarget; 2016 Aug; 7(35):57160-57170. PubMed ID: 27494835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates.
    Xu L; Wang Y; Zhu C; Ren S; Shao Y; Wu L; Li W; Jia X; Hu R; Chen R; Chen Z
    Theranostics; 2020; 10(18):8162-8178. PubMed ID: 32724464
    [No Abstract]   [Full Text] [Related]  

  • 23. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo.
    Kennel SJ; Woodward JD; Rondinone AJ; Wall J; Huang Y; Mirzadeh S
    Nucl Med Biol; 2008 May; 35(4):501-14. PubMed ID: 18482688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photosensitizer-Conjugated Hyaluronic Acid-Shielded Polydopamine Nanoparticles for Targeted Photomediated Tumor Therapy.
    Han J; Park W; Park SJ; Na K
    ACS Appl Mater Interfaces; 2016 Mar; 8(12):7739-47. PubMed ID: 26965036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable nanoparticles for direct or two-step tumor immunotargeting.
    Nobs L; Buchegger F; Gurny R; Allémann E
    Bioconjug Chem; 2006; 17(1):139-45. PubMed ID: 16417262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stiffness of targeted layer-by-layer nanoparticles impacts elimination half-life, tumor accumulation, and tumor penetration.
    Kong SM; Costa DF; Jagielska A; Van Vliet KJ; Hammond PT
    Proc Natl Acad Sci U S A; 2021 Oct; 118(42):. PubMed ID: 34649991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
    Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
    Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of an Amphiphilic Poly(aspartamide)-mediated Self-assembled Nanoconstruct for Long-Term Tumor Targeting and Bioimaging.
    Cherukula K; Uthaman S; Park IK
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30832383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
    Shi J; Xiao Z; Kamaly N; Farokhzad OC
    Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered nanomedicine for myeloma and bone microenvironment targeting.
    Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics.
    Natarajan A; Gruettner C; Ivkov R; DeNardo GL; Mirick G; Yuan A; Foreman A; DeNardo SJ
    Bioconjug Chem; 2008 Jun; 19(6):1211-8. PubMed ID: 18517234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity.
    Houdaihed L; Evans JC; Allen C
    Pharm Res; 2020 Jan; 37(3):39. PubMed ID: 31965330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
    Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches.
    Al-Taie A; Özcan Bülbül E
    J Drug Target; 2024 Dec; 32(1):45-56. PubMed ID: 38096045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.
    Lu L; Kang S; Sun C; Sun C; Guo Z; Li J; Zhang T; Luo X; Liu B
    Curr Top Med Chem; 2020; 20(27):2427-2441. PubMed ID: 32842941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles.
    Valencia PM; Hanewich-Hollatz MH; Gao W; Karim F; Langer R; Karnik R; Farokhzad OC
    Biomaterials; 2011 Sep; 32(26):6226-33. PubMed ID: 21658757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust Strategy for Antibody-Polymer-Drug Conjugation: Significance of Conjugating Orientation and Linker Charge on Targeting Ability.
    Wan J; Li Y; Jin K; Guo J; Xu J; Wang C
    ACS Appl Mater Interfaces; 2020 May; 12(21):23717-23725. PubMed ID: 32368886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
    Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
    Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.